A randomized, double-blind, placebo-controlled study of oral hydrolytic enzymes in relapsing multiple sclerosis

Multiple Sclerosis

Volumn 11, Issue 2, 2005, Pages 166-168

  Baumhackl, Ulf ^a   Kappos, L ^b   Radue, E W ^b   Freitag, P ^b   Guseo, A ^c   Daumer, A ^d   Mertin, J ^e  

^a Central Clinic   (Austria)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c Department of Neurology   (Hungary)

^d UNIVERSITY OF MUNICH   (Germany)

^e Clinic Bad Windsheim   (Germany)

Author keywords

Hydrolytic enzymes; Multiple sclerosis; Therapy

Indexed keywords

BROMELAIN; HYDROLASE; PLACEBO; RUTOSIDE; TRYPSIN;

ADULT; ALLERGIC ENCEPHALOMYELITIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DISEASE COURSE; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; STATISTICAL SIGNIFICANCE; TREATMENT FAILURE;

ADMINISTRATION, ORAL; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BROMELAINS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PLACEBOS; RECURRENCE; RUTIN; TREATMENT OUTCOME; TRYPSIN;

EID: 15544381262     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1191/1352458505ms1132oa     Document Type: Article

References (7)

1. Neuhofer C. Enzymtherapie bei Multipler Sklerose. Hufeland J 1986; 2: 47-50.
2. Baumhackl U, Födermair S. Enzymtherapie bei Multipler Sklerose. Allgemeinmedizin 1990; 19: 169-72.
3. Taragoni OS, Tary-Lehmann M, Lehmann PV. Prevention of murine EAE by oral hydrolytic enzyme treatment. J Autoimmun 1999; 12 191-98.
4. Desser L, Rehberger A, Kokron E. Cytokine synthesis in human peripheral blood mononuclear cells after oral administration of polyenzyme preparations. Oncology 1993; 50: 403-407.
5. Lehmann PV. Immunomodulation by proteolytic enzymes. Nephrol Dial Transplant 1996; 11: 953-55.
6. Stauder G, Donnerstag B, Baumhackl U, Buschmans E. Use of oral enzymes in multiple sclerosis: phenotyping of peripheral blood lymphocytes from MS patients under longterm treatment with orally administered hydrolytic enzymes. Int J Immunotherapy 1997; 13 135-37
7. Poser C, Paty D, Scheinberg L, McDonald W, Davis D, Ebers G et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-31.